Clinical Trial Update: Low-dose Pentavalent Antimony Treatment of Cutaneous Leishmaniasis in Old Age Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating low-dose meglumine antimoniate (pentavalent antimony) for localized cutaneous leishmaniasis in older adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Localized Cutaneous Leishmaniasis

Drugs mentioned

• Meglumine antimoniate (meglumine antimoniate)

Snippet

Sponsor: University of Brasilia | Conditions: Localized Cutaneous Leishmaniasis | Phase 4 | Status: COMPLETED